AACC 2019

Thank you for joining us at AACC this year.

Visitors to our booth explored the latest innovations in laboratory medicine and learned how laboratories of all sizes can benefit from automation.

Check out scientific posters presented at the event and learn more about the solutions showcased. 

Elevate your performance. Advance patient care.

Download Scientific Posters Presented at AACC 2019

AACC 2019 Scientific Poster: Predicted Economic Benefits of a Novel Biomarker for Earlier Sepsis Identification and Treatment

Poster Benefits of a Novel Biomarker for Earlier Sepsis Identification

Is your hospital seeking ways to improve the economics and outcomes of sepsis? This study—awarded Best Abstract at AACC 2019—showed how solutions that speed time to antibiotics for sepsis patients in the ED can deliver economic savings to hospitals.

AACC 2019 Scientific Poster: Extending the Linear Reading Range of a Luminometer

Poster Extending the Linear Reading of a Luminometer

Non-linearity of the relationship between sample light output and photon counts or relative light unit can lead to imprecision of concentration results. Presented at AACC 2019, see the results of a study comparing chemiluminescence immunoassays with the traditional photon counting method and the combined counting method.

AACC 2019 Scientific Poster: Improved Chemiluminescent Substrate

Poster A New and Improved Chemiluminscent Substrate

When it comes to immunoassay performance characteristics, the substrate of an assay makes a difference. In this study, presented at AACC 2019, find out how the new LumiFAST chemiluminescent substrate generated better light signal response than the Lumi-Phos 530 substrate.

AACC 2019 Scientific Poster: Improvements in Precision of Low-volume Pipetting on an Automated Analyzer

Poster Improvements in Precision of Low-volume Pipetting on an Automated Analyzer

Automated analyzers have improved precision and accuracy of patient samples. However, the desire to conserve patient samples collected has led to a need for even smaller volume sample delivery. Find out how a team set out to develop motion profiles that would help achieve very high precision (<1% CV) for small volume delivery—while maintaining fast throughput and eliminating sample carryover with disposable pipette tips.

AACC 2019 Scientific Poster: Analytical Performance Characteristics of the New Beckman Coulter Access PCT Assay

Poster Analytical Performance Characteristics of Access PCT

Review the evidence demonstrating strong correlation and concordance of the Access PCT immunoassay to a well-established PCT predicate method. Showcased at AACC 2019, this clinical laboratory study confirms the precision and reproducibility of Access PCT assay results, which are returned within 20 minutes.

AACC 2019 Scientific Poster: Development of an Assay for Measurement of Total Immunoglobulin on AU Chemistry Analyzers

Poster Development of an Assay for Measurement of Total IgE

IgE is a member of the immunoglobulin family of proteins produced by plasma cells. Elevated levels are commonly seen in cases of allergic diseases and other conditions. Read this development study presented at AACC 2019 evaluating the performance of a new Total IgE assay.



Thank you for joining us at the AACC laboratory medicine conference which took place this year in Orange County, California, a community that we and our local associates have been privileged to serve for over 80 years. Visitors to our booth at the Anaheim Convention Center networked with clinical laboratory peers and heard from scientific experts. They learned about cutting-edge advancements in clinical chemistry, hematology, clinical information management tools, laboratory automation and more.

Bring the benefit of automation for all

Automation isn’t just for ultra high-volume laboratories. With configurations for low-, mid- and high-volume laboratories in our booth, visitors could:
  • Get an in-depth view of how the innovative DxA 5000* total laboratory automation system (coming soon) helps deliver unparalleled rapid and consistent turnaround times, provides a new level of comprehensive preanalytical sample quality detection and significantly reduces the number of manual processing steps to improve laboratory efficiency
  • See how the modular open platform of the Copan WASP® DT: Walkaway Specimen Processor adapts to the changing needs of your clinical microbiology laboratory. Visitors found out how they could automate all core aspects of microbiology specimen processing, including plating and streaking, Gram-stain slide preparation and enrichment broth inoculation

Deliver greater insights through clinical informatics

We helped visitors identify ways to save time, increase productivity and deliver greater insights with the DxONE clinical informatics portfolio, featuring:

Accelerate care with a menu that matters

Visitors learned how laboratories can empower clinical staff in identifying prevalent and costly health risks sooner with solutions such as:

Have questions regarding our menu? Contact your Beckman Coulter sales representative to schedule time with a scientific expert.

Unlock hidden value through performance partnership

Visitors discovered how their peers are saving costs, improving efficiency and preparing their laboratories for the future with Danaher Business System workflow consultation.

A Race against Time –— the Challenge of Sepsis for Clinicians and Laboratorians

Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. It is estimated that this condition affects approximately 30 million1 people worldwide every year and carries a 25–-30% mortality rate. Sepsis is also costly to healthcare organizations, with more than $24 billionspent on it annually in the United States alone.

Early detection and diagnosis are key to stopping the progression of sepsis. Join us for this educational event at the 71st AACC Annual Scientific Meeting to hear from a panel of experts about the diagnosis and treatment of this deadly condition.

Attendees will learn to: 
  • Describe the healthcare burden of sepsis
  • Summarize the clinical guidelines used in establishing a sepsis protocol
  • Discuss the roles of the various stakeholders in the diagnosis and management of sepsis
  • Discuss sepsis biomarkers and antibiotic stewardship


Time Topic Speaker

Tuesday, August 6
7:00 –8:30 a.m.
Hilton Anaheim,
Pacific AB Room

 A Race against Time – the Challenge of Sepsis for Clinicians and Laboratorians Jeannine Holden, M.D., (moderator)
Chief Medical Officer and Vice President, Medical and Scientific Affairs
Beckman Coulter, Inc., Brea, CA

  • Sepsis clinical presentation, current challenges in clinical assessment
  • Current sepsis protocol
  • Emerging diagnostic technology (the Early Sepsis Indicator)
David Huang, M.D., M.P.H. (clinician perspective) 
Associate Professor of Critical Care Medicine and Emergency Medicine
Department of Critical Care Medicine
University of Pittsburgh School of Medicine 

  • How the lab supports the sepsis protocol in your medical institution 
  • Key elements/components for managing the protocol
  • Lab tests to support sepsis management (lactate, procalcitonin, etc.)
Octavia Peck-Palmer, Ph.D. (laboratorian perspective)
Associate Professor, Departments of Pathology, Critical Care Medicine, and Clinical and Translational Science, University of Pittsburgh School of Medicine 
Medical Director, Automated Testing Laboratories, UPMC Presbyterian, Shadyside, and Children's Hospital of Pittsburgh, PA

Sepsis and antibiotic stewardship Barbara Zimmer, Ph.D. (antibiotic stewardship and sepsis)
Principal Scientist, Scientific Affairs
Beckman Coulter, Inc., Brea, CA


Joint Industry-sponsored Workshop developed in partnership with AACC:

The Fourth Universal Definition of Myocardial Infarction (MI) in Conjunction with the Clinical Laboratory Practice Recommendations for the Use of High-sensitivity Cardiac Troponin in Acute Coronary Syndrome

Includes interactive panel discussion led by experts from the IFCC Committee on Clinical Applications of Cardiac Biomarkers.

Fred S. Apple, Ph.D., D.A.B.C.C., F.A.C.S.M.
Alan Jaffe, M.D.
Richard Body, M.B. Ch.B, M.R.C.S.Ed. (A&E), F.R.C.E.M., Ph.D.
Peter Kavsak, Ph.D., F.C.A.C.B., F.A.A.C.C., F.C.C.S.

Paul Collinson, M.D.
Amy Saenger, Ph.D., D.A.B.C.C. 
Alan Wu, Ph.D., D.A.B.C.C.
Martin Than, M.D.

Wednesday, August 7, 2019
7:00–8:30 a.m.

Hilton Anaheim: California Ballrooms C/D

Consensus recommendations with the Fourth Universal Definition of Myocardial Infarction guidelines reinforce guidance on the use of high-sensitivity cardiac troponin assays published by the AACC Academy Laboratory Medicine Practice group and IFCC Committee on Clinical Applications of Biomarkers. This workshop provides cross-discipline (laboratory, emergency medicine, cardiology) commentary with evidence-based rule-out, diagnostic and risk assessment clinical studies addressing: QC utilization, reportable analytical limits, units for reporting, sex-specific 99th percentiles, defining high-sensitivity assays, preanalytic/analytic challenges, harmonizing assays, turnaround times, and biological variabilities in interpreting serial (delta) collections. A multidisciplinary expert panel will address audience questions.

Expected Outcomes

1. Understand the laboratory medicine expert recommendations* along with the Fourth Universal Definition of Myocardial Infarction** for the use of high-sensitivity cardiac troponin in acute coronary syndromes including impact to emergency medicine, cardiology and laboratory medicine. 

2. Become educated on the analytical characteristics unique to high-sensitivity cardiac troponin assays, how they differ from contemporary and POC assays, as well as guidance on how to implement high-sensitivity cardiac troponin assays in clinical practice.

3. Explore clinical and analytical challenges encountered in daily practice by the laboratory, emergency medicine and cardiology following implementation with an interactive expert panel discussion and audience engagement.

A continental breakfast will be included

Register for MI workshop

* Wu AHB, Christenson RH, Greene DN, Jaffe AS, Kavsak PA, Ordonez-Llanos J, Apple FS. Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2018;64:545–655.

** Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto F, Antman EM, Hamm CW, De Caterina R, Januzzi J, Apple FS, Garcia AA, Underwood R, Canty J, Lyon A, Devereaux PJ, Jamorano JL, Lindahl B, Weintraub W, Newby LK, Virmani R, Vranckx R, Cutlip D, Gibbons R, Smith RC, Atar D, Luepker RW, Robertson RM, Bonow R, Steg P, O’Gara P, Fox KA. Fourth Universal Definition of Myocardial Infarction. J Amer Coll Cardiol. 2018:72:2231–2264.

1Sepsis Alliance. “Fact Sheet.2018.” Sepsis.org. Accessed 6 Mar. 2019.

2Torio C, Moore B. “National Inpatient Hospital Costs: The Most Expensive Conditions by Payer.” www.hcup-us.ahrq.gov/reports/statbriefs/sb204-Most-Expensive-Hospital-Conditions.pdf, May 2016. Accessed 15 Jan. 2018.

Danaher and its service marks are owned by Danaher Corporation and used with permission.